{"id":8604,"date":"2023-10-01T23:10:04","date_gmt":"2023-10-01T23:10:04","guid":{"rendered":"https:\/\/mdxcro.com\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\/"},"modified":"2026-02-09T10:49:17","modified_gmt":"2026-02-09T10:49:17","slug":"entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica","status":"publish","type":"post","link":"https:\/\/mdxcro.com\/es\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\/","title":{"rendered":"Entendiendo el MDCG 2020-13: una gu\u00eda para fabricantes de dispositivos m\u00e9dicos que preparan informes de evaluaci\u00f3n cl\u00ednica"},"content":{"rendered":"\n<p>The <a href=\"https:\/\/health.ec.europa.eu\/medical-devices-dialogue-between-interested-parties\/medical-device-coordination-group-working-groups_en\">Medical Device Coordination Group (MDCG)<\/a> shapes how medical devices are assessed in the European Union. One of its most influential documents is\u00a0<strong>MDCG 2020-13<\/strong>, a guideline that explains how manufacturers should prepare Clinical Evaluation Reports (CERs) under the EU Medical Device Regulation (MDR). For any company aiming to place a device on the EU market, understanding\u00a0<strong>MDCG 2020-13 for Manufacturers<\/strong>\u00a0is essential.<\/p>\n\n<h2 class=\"wp-block-heading\"><strong>Why MDCG 2020-13 Matters for Manufacturers<\/strong><\/h2>\n\n<p>The MDR introduced a stricter and far more structured compliance framework. Clinical Evaluation Reports are no longer a formality\u2014they are central to demonstrating safety, performance, and clinical benefit.<\/p>\n\n<p><strong>MDCG 2020-13 for Manufacturers<\/strong>\u00a0provides the roadmap for building a CER that meets MDR expectations. Aligning with this guidance improves the quality of your Technical Documentation and significantly strengthens your chances of regulatory approval.<\/p>\n\n<p>Clinical evaluation is now a continuous process, and MDCG 2020-13 ensures manufacturers understand\u00a0<strong>what data to collect, how to justify it, and how to present it<\/strong>.<\/p>\n\n<h2 class=\"wp-block-heading\"><strong>How MDCG 2020-13 Shapes the <a href=\"https:\/\/mdxcro.com\/es\/informe-de-evaluacion-clinica-mdr-se-explican-las-funciones-de-meddev-y-mdcg\/\">Clinical Evaluation Process<\/a><\/strong> (CER)<\/h2>\n\n<p>MDCG 2020-13 serves as a practical reference for structuring clinical evidence. It explains what the CER must include and aligns its structure with MDR Annex XIV, ensuring manufacturers remain fully compliant with current regulations.<\/p>\n\n<p>The guideline helps manufacturers:<\/p>\n\n<ul class=\"wp-block-list\">\n<li>Understand the level of clinical data required<\/li>\n\n\n\n<li>Present evidence in a regulatory\u2011ready format<\/li>\n\n\n\n<li>Show benefit\u2011risk alignment with MDR safety principles<\/li>\n<\/ul>\n\n<p><strong>For manufacturers, this guidance reduces ambiguity and supports consistent, defensible clinical evaluations.<\/strong><\/p>\n\n<h2 class=\"wp-block-heading\"><strong>What You Need to Know About Aligning CERs With the CEAR Format<\/strong><\/h2>\n\n<p>Manufacturers may structure their Clinical Evaluation Report to follow the\u00a0<strong>Clinical Evaluation Assessment Report (CEAR)<\/strong>\u00a0used by Notified Bodies.<br\/>Why does this matter?<\/p>\n\n<ul class=\"wp-block-list\">\n<li>It creates a smoother review process<\/li>\n\n\n\n<li>It improves clarity and traceability<\/li>\n\n\n\n<li>It anticipates NB expectations<\/li>\n<\/ul>\n\n<p>Using the CEAR structure is not mandatory, but it can streamline regulatory interactions and reduce back\u2011and\u2011forth during conformity assessments.<\/p>\n\n<h2 class=\"wp-block-heading\"><strong>Key Goals of the <a href=\"https:\/\/mdxcro.com\/es\/5-pasos-para-disenar-la-plantilla-de-tu-plan-de-evaluacion-clinica\/\">Clinical Evaluation Plan<\/a> Under MDCG 2020\u201113<\/strong><\/h2>\n\n<p>MDCG 2020-13 reinforces the importance of a well\u2011defined\u00a0<strong>Clinical Evaluation Plan (CEP)<\/strong>. Manufacturers must align it with MDR Annex XIV Part A Section 1a. The CEP should clearly define:<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>\u2714 General Safety and Performance Requirements (GSPRs)<\/strong><\/h3>\n\n<p>Identify which GSPRs require clinical evidence and describe how that evidence will be generated.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>\u2714 Intended Purpose<\/strong><\/h3>\n\n<p>Ensure consistency across the CER, IFU, labeling, and promotional materials.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>\u2714 Target Populations and Indications<\/strong><\/h3>\n\n<p>Include patient groups, contraindications, and specific clinical conditions.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>\u2714 Clinical Benefits and Outcome Measures<\/strong><\/h3>\n\n<p>Define measurable clinical outcomes linked to meaningful patient benefit.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>\u2714 Clinical Safety Methods<\/strong><\/h3>\n\n<p>Explain how both qualitative and quantitative aspects of safety will be assessed.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>\u2714 Benefit\u2011Risk Parameters<\/strong><\/h3>\n\n<p>List all metrics and criteria used to justify the benefit\u2011risk determination.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>\u2714 Special Considerations for Combination Products<\/strong><\/h3>\n\n<p>Address components such as medicinal substances, tissues of animal origin, or human derivatives.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>\u2714 Clinical Development Plan<\/strong><\/h3>\n\n<p>Include milestones and acceptance criteria\u2014even if only high level.<\/p>\n\n<p>A well\u2011designed CEP sets the foundation for a successful clinical evaluation and a strong CER.<\/p>\n\n<h1 class=\"wp-block-heading\"><strong>Aligning IFU, Promotional Materials, and the CER Using MDCG 2020-13<\/strong><\/h1>\n\n<p>One of the most practical aspects of\u00a0<strong>MDCG 2020-13 for Manufacturers<\/strong>\u00a0is its guidance on aligning all outward\u2011facing documents with the CER.<\/p>\n\n<p>Here\u2019s what manufacturers must evaluate:<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>Information Materials<\/strong><\/h3>\n\n<p>Review IFUs, labeling, SSCPs, and promotional materials to ensure they reflect the evidence presented in the CER.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>Intended Purpose<\/strong><\/h3>\n\n<p>The intended purpose described in the CER must match exactly what appears in the IFU and promotional claims.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>Patient Population and User Groups<\/strong><\/h3>\n\n<p>Ensure consistency in population definitions and user profiles (HCP vs. lay user).<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>Warnings, Contraindications, and Precautions<\/strong><\/h3>\n\n<p>Verify that safety information in the IFU is backed by data in the CER and risk management file.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>Training Requirements<\/strong><\/h3>\n\n<p>If user training is needed, justify this in both the risk management documentation and the CER.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>Associated Risks and Residual Risks<\/strong><\/h3>\n\n<p>Ensure risk descriptions align across the CER, IFU, PMS\/PSUR, and RMF.<\/p>\n\n<p>This alignment not only supports MDR compliance but also ensures safe, transparent communication to patients and users.<\/p>\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"has-white-frost-color has-blue-background-color has-text-color has-background has-link-color has-medium-font-size wp-elements-f5d2de36d49042c12ddf2827aa8ba85c\">By aligning these documents in accordance with MDCG 2020-13, manufacturers not only assure compliance but also build a strong foundation for market success, bolstered by robust clinical evidence and transparent communication.<\/p>\n<\/blockquote>\n\n<h2 class=\"wp-block-heading\">How to Incorporate these Aspects in Your Clinical Evaluation<\/h2>\n\n<h3 class=\"wp-block-heading\"><strong>1. Start With a Gap Analysis<\/strong><\/h3>\n\n<p>Compare your existing CER and CEP against the MDCG 2020-13 requirements.<br\/>This identifies missing data, unclear claims, or inconsistencies.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>2. Use a Multidisciplinary Team<\/strong><\/h3>\n\n<p>Combine expertise from clinical, regulatory, engineering, and risk management.<br\/>This ensures your CER is scientifically sound and fully compliant.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>3. Update Documentation<\/strong><\/h3>\n\n<p>Revise the CEP, CER, and supporting Technical Documentation based on identified gaps.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>4. Ensure Consistent Device Descriptions<\/strong><\/h3>\n\n<p>Match the device description across the CER, IFU, marketing materials, and SSCP.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>5. Integrate All Available Clinical Data<\/strong><\/h3>\n\n<p>Include pre\u2011clinical data, clinical investigations, PMS results, PMCF findings, and real\u2011world evidence.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>6. Leverage PMS and PSUR Insights<\/strong><\/h3>\n\n<p>Use post\u2011market data to strengthen the CER and ensure continuous compliance.<\/p>\n\n<h3 class=\"wp-block-heading\"><strong>7. Align With the Risk Management File<\/strong><\/h3>\n\n<p>Make sure risk\u2011related statements remain consistent across all documents.<\/p>\n\n<p>By taking these steps, manufacturers can confidently align with\u00a0<strong>MDCG 2020-13<\/strong>, strengthen their clinical evidence, and support a smooth Notified Body review.<\/p>\n\n<h2 class=\"wp-block-heading\"><strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-blue-color\">Why MDCG 2020-13 for Manufacturers Is a Strategic Advantage<\/mark><\/strong><\/h2>\n\n<p>This guideline is far more than a compliance requirement. It helps manufacturers:<\/p>\n\n<ul class=\"wp-block-list\">\n<li>Build stronger, defensible clinical evidence<\/li>\n\n\n\n<li>Reduce regulatory delays<\/li>\n\n\n\n<li>Improve device safety and performance claims<\/li>\n\n\n\n<li>Strengthen market readiness<\/li>\n\n\n\n<li>Ensure consistent messaging across all documentation<\/li>\n<\/ul>\n\n<p>With MDCG 2020-13, manufacturers can elevate the quality and credibility of their clinical evaluations\u2014while accelerating time\u2011to\u2011market under the MDR.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Medical Device Coordination Group (MDCG) shapes how medical devices are assessed in the European Union. One of its most influential documents is\u00a0MDCG 2020-13, a guideline that explains how manufacturers should prepare Clinical Evaluation Reports (CERs) under the EU Medical Device Regulation (MDR). For any company aiming to place a device on the EU market, [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":5903,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[216],"tags":[],"resources-sector":[180],"class_list":["post-8604","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","resources-sector-medical-devices"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MDCG 2020-13 para fabricantes | MDx CRO<\/title>\n<meta name=\"description\" content=\"Explore los aspectos esenciales del MDCG 2020-13 y su impacto en la Evaluaci\u00f3n Cl\u00ednica. La gu\u00eda para fabricantes de dispositivos m\u00e9dicos que se dirigen a los mercados de la UE.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mdxcro.com\/es\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MDCG 2020-13 para fabricantes | MDx CRO\" \/>\n<meta property=\"og:description\" content=\"Explore los aspectos esenciales del MDCG 2020-13 y su impacto en la Evaluaci\u00f3n Cl\u00ednica. La gu\u00eda para fabricantes de dispositivos m\u00e9dicos que se dirigen a los mercados de la UE.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mdxcro.com\/es\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\/\" \/>\n<meta property=\"og:site_name\" content=\"MDx CRO\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-01T23:10:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-09T10:49:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2022\/10\/AdobeStock_77960083-scaled-e1696197274511.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"427\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Admin Met\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Admin Met\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\\\/\"},\"author\":{\"name\":\"Admin Met\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/#\\\/schema\\\/person\\\/4b6859b1038304bf5649e1c0e29dc43d\"},\"headline\":\"Entendiendo el MDCG 2020-13: una gu\u00eda para fabricantes de dispositivos m\u00e9dicos que preparan informes de evaluaci\u00f3n cl\u00ednica\",\"datePublished\":\"2023-10-01T23:10:04+00:00\",\"dateModified\":\"2026-02-09T10:49:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\\\/\"},\"wordCount\":931,\"publisher\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mdxcro.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AdobeStock_77960083-scaled-e1696197274511.jpeg\",\"articleSection\":[\"blog\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\\\/\",\"url\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\\\/\",\"name\":\"MDCG 2020-13 para fabricantes | MDx CRO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mdxcro.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AdobeStock_77960083-scaled-e1696197274511.jpeg\",\"datePublished\":\"2023-10-01T23:10:04+00:00\",\"dateModified\":\"2026-02-09T10:49:17+00:00\",\"description\":\"Explore los aspectos esenciales del MDCG 2020-13 y su impacto en la Evaluaci\u00f3n Cl\u00ednica. La gu\u00eda para fabricantes de dispositivos m\u00e9dicos que se dirigen a los mercados de la UE.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/mdxcro.com\\\/es\\\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mdxcro.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AdobeStock_77960083-scaled-e1696197274511.jpeg\",\"contentUrl\":\"https:\\\/\\\/mdxcro.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AdobeStock_77960083-scaled-e1696197274511.jpeg\",\"width\":640,\"height\":427},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Entendiendo el MDCG 2020-13: una gu\u00eda para fabricantes de dispositivos m\u00e9dicos que preparan informes de evaluaci\u00f3n cl\u00ednica\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/\",\"name\":\"MDx CRO\",\"description\":\"Investigaci\u00f3n cl\u00ednica, normativa y control de calidad en tecnolog\u00eda m\u00e9dica y diagn\u00f3stico in vitro\",\"publisher\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/#organization\"},\"alternateName\":\"MDx\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/#organization\",\"name\":\"CRO de MDx\",\"url\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/mdxcro.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/MDX.svg\",\"contentUrl\":\"https:\\\/\\\/mdxcro.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/MDX.svg\",\"width\":352,\"height\":114,\"caption\":\"CRO de MDx\"},\"image\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/medtech-ivd-cro\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/es\\\/#\\\/schema\\\/person\\\/4b6859b1038304bf5649e1c0e29dc43d\",\"name\":\"Admin Met\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"caption\":\"Admin Met\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MDCG 2020-13 para fabricantes | MDx CRO","description":"Explore los aspectos esenciales del MDCG 2020-13 y su impacto en la Evaluaci\u00f3n Cl\u00ednica. La gu\u00eda para fabricantes de dispositivos m\u00e9dicos que se dirigen a los mercados de la UE.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mdxcro.com\/es\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\/","og_locale":"es_ES","og_type":"article","og_title":"MDCG 2020-13 para fabricantes | MDx CRO","og_description":"Explore los aspectos esenciales del MDCG 2020-13 y su impacto en la Evaluaci\u00f3n Cl\u00ednica. La gu\u00eda para fabricantes de dispositivos m\u00e9dicos que se dirigen a los mercados de la UE.","og_url":"https:\/\/mdxcro.com\/es\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\/","og_site_name":"MDx CRO","article_published_time":"2023-10-01T23:10:04+00:00","article_modified_time":"2026-02-09T10:49:17+00:00","og_image":[{"width":640,"height":427,"url":"https:\/\/mdxcro.com\/wp-content\/uploads\/2022\/10\/AdobeStock_77960083-scaled-e1696197274511.jpeg","type":"image\/jpeg"}],"author":"Admin Met","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Admin Met","Tiempo de lectura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mdxcro.com\/es\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\/#article","isPartOf":{"@id":"https:\/\/mdxcro.com\/es\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\/"},"author":{"name":"Admin Met","@id":"https:\/\/mdxcro.com\/es\/#\/schema\/person\/4b6859b1038304bf5649e1c0e29dc43d"},"headline":"Entendiendo el MDCG 2020-13: una gu\u00eda para fabricantes de dispositivos m\u00e9dicos que preparan informes de evaluaci\u00f3n cl\u00ednica","datePublished":"2023-10-01T23:10:04+00:00","dateModified":"2026-02-09T10:49:17+00:00","mainEntityOfPage":{"@id":"https:\/\/mdxcro.com\/es\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\/"},"wordCount":931,"publisher":{"@id":"https:\/\/mdxcro.com\/es\/#organization"},"image":{"@id":"https:\/\/mdxcro.com\/es\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\/#primaryimage"},"thumbnailUrl":"https:\/\/mdxcro.com\/wp-content\/uploads\/2022\/10\/AdobeStock_77960083-scaled-e1696197274511.jpeg","articleSection":["blog"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/mdxcro.com\/es\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\/","url":"https:\/\/mdxcro.com\/es\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\/","name":"MDCG 2020-13 para fabricantes | MDx CRO","isPartOf":{"@id":"https:\/\/mdxcro.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mdxcro.com\/es\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\/#primaryimage"},"image":{"@id":"https:\/\/mdxcro.com\/es\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\/#primaryimage"},"thumbnailUrl":"https:\/\/mdxcro.com\/wp-content\/uploads\/2022\/10\/AdobeStock_77960083-scaled-e1696197274511.jpeg","datePublished":"2023-10-01T23:10:04+00:00","dateModified":"2026-02-09T10:49:17+00:00","description":"Explore los aspectos esenciales del MDCG 2020-13 y su impacto en la Evaluaci\u00f3n Cl\u00ednica. La gu\u00eda para fabricantes de dispositivos m\u00e9dicos que se dirigen a los mercados de la UE.","breadcrumb":{"@id":"https:\/\/mdxcro.com\/es\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mdxcro.com\/es\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/mdxcro.com\/es\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\/#primaryimage","url":"https:\/\/mdxcro.com\/wp-content\/uploads\/2022\/10\/AdobeStock_77960083-scaled-e1696197274511.jpeg","contentUrl":"https:\/\/mdxcro.com\/wp-content\/uploads\/2022\/10\/AdobeStock_77960083-scaled-e1696197274511.jpeg","width":640,"height":427},{"@type":"BreadcrumbList","@id":"https:\/\/mdxcro.com\/es\/entendiendo-el-mdcg-2020-13-una-guia-para-fabricantes-de-dispositivos-medicos-que-preparan-informes-de-evaluacion-clinica\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mdxcro.com\/es\/"},{"@type":"ListItem","position":2,"name":"Entendiendo el MDCG 2020-13: una gu\u00eda para fabricantes de dispositivos m\u00e9dicos que preparan informes de evaluaci\u00f3n cl\u00ednica"}]},{"@type":"WebSite","@id":"https:\/\/mdxcro.com\/es\/#website","url":"https:\/\/mdxcro.com\/es\/","name":"MDx CRO","description":"Investigaci\u00f3n cl\u00ednica, normativa y control de calidad en tecnolog\u00eda m\u00e9dica y diagn\u00f3stico in vitro","publisher":{"@id":"https:\/\/mdxcro.com\/es\/#organization"},"alternateName":"MDx","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mdxcro.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/mdxcro.com\/es\/#organization","name":"CRO de MDx","url":"https:\/\/mdxcro.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/mdxcro.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/MDX.svg","contentUrl":"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/MDX.svg","width":352,"height":114,"caption":"CRO de MDx"},"image":{"@id":"https:\/\/mdxcro.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/medtech-ivd-cro"]},{"@type":"Person","@id":"https:\/\/mdxcro.com\/es\/#\/schema\/person\/4b6859b1038304bf5649e1c0e29dc43d","name":"Admin Met","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","caption":"Admin Met"}}]}},"_links":{"self":[{"href":"https:\/\/mdxcro.com\/es\/wp-json\/wp\/v2\/posts\/8604","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mdxcro.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mdxcro.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mdxcro.com\/es\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/mdxcro.com\/es\/wp-json\/wp\/v2\/comments?post=8604"}],"version-history":[{"count":3,"href":"https:\/\/mdxcro.com\/es\/wp-json\/wp\/v2\/posts\/8604\/revisions"}],"predecessor-version":[{"id":9555,"href":"https:\/\/mdxcro.com\/es\/wp-json\/wp\/v2\/posts\/8604\/revisions\/9555"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mdxcro.com\/es\/wp-json\/wp\/v2\/media\/5903"}],"wp:attachment":[{"href":"https:\/\/mdxcro.com\/es\/wp-json\/wp\/v2\/media?parent=8604"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mdxcro.com\/es\/wp-json\/wp\/v2\/categories?post=8604"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mdxcro.com\/es\/wp-json\/wp\/v2\/tags?post=8604"},{"taxonomy":"resources-sector","embeddable":true,"href":"https:\/\/mdxcro.com\/es\/wp-json\/wp\/v2\/resources-sector?post=8604"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}